Key points in the management of gastroesophageal reflux disease.
Baldi
Fabio
F
Motility Unit, Department of Gastroenterology, S.Orsola-Malpighi Hospital, via Massarenti 9, 40138 Bologna, Italy. fabio.baldi@aosp.bo.it
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D050782:Esophageal pH Monitoring; D005764:Gastroesophageal Reflux / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole